This month's main topic: QuarterWatchTM (includes new data from Quarter 4, 2018 and Quarter 1, 2019): Focus on Four New Drugs: Xofluza, Aimovig, Ajovy, and Emgality
ISMP Medication Safety Alert!®
Community/Ambulatory
A valuable resource to reduce medication error risk in outpatient settings
The ISMP Medication Safety Alert!®Community/Ambulatory Care is a 4-5 page digital newsletter, published monthly for healthcare practitioners in ambulatory settings, including community pharmacies, outpatient clinics, physician offices, and state institutions.
Who reads this newsletter?
- Community/ambulatory care pharmacists
- Pharmacy managers and executives
- Pharmacy technicians and other pharmacy staff
- Physicians and nurses in ambulatory practice
- Anyone concerned with medication safety
Subscription Information
- Twelve (12) issues per year
- One-year subscription rate: $64.00
- Distributed via email on a monthly basis
- Special pricing for group purchases; contact ISMP
- One-year subscriptions start from the date of purchase. You will be granted access to issues released after date of purchase for one year. This does not include access to back issues.
Topics
Browse Issues
Community/Ambulatory
Volume 18, Issue 7
This month's main topic: New Recommendations to Improve Drug Allergy Capture and Clinical Decision Support
Community/Ambulatory
Volume 18, Issue 6
This month's main topic: As Approval of Medical Cannabis Spreads State by State, Product Labeling Improvements Are a Must
Community/Ambulatory
Volume 18, Issue 5
This month's main topic: Prescription Price Checks and Medication Errors
Community/Ambulatory
Volume 18, Issue 4
This month's main topic: ISMP Celebrates Your Contribution to Our Success During Our 25th Anniversary
Community/Ambulatory
Volume 18, Issue 3
This month's main topic: Top 10 Tips for Keeping Pets Safe Around Human Medications
Community/Ambulatory
Volume 18, Issue 2
This month's main topic: Opioid Misuse in Older Adults
Community/Ambulatory
Volume 18, Issue 1
This month's main topic: Are National Efforts to Reduce Drug Name Confusion Paying Off?
Community/Ambulatory
Volume 17, Issue 12
This month's main topic: QuarterWatch™ (includes Data through June 2018): Focus on Newly Approved Drugs
Community/Ambulatory
Volume 17, Issue 11
This month's main topic: Achieve Long-term Remedies Through Reporting and Second-order Problem Solving
Community/Ambulatory
Volume 17, Issue 10
This month's main topic: Safety and Reliability Require a State of Mindfulness
Community/Ambulatory
Volume 17, Issue 9
This month's main topic: QuarterWatch™ (2017 Annual report): Four Severe Adverse Events and the Leading Suspect Drugs
Community/Ambulatory
Volume 17, Issue 8
This month's main topic: Call to Action: Longstanding Strategies to Prevent Accidental Daily Methotrexate Dosing Must be Implemented
Community/Ambulatory
Volume 17, Issue 7
This month's main topic: Weathering the Storm: Managing the Drug Shortage Crisis
Community/Ambulatory
Volume 17, Issue 6
This month's main topic: ISMP National Vaccine Errors Reporting Program 2017 Analysis: Vaccine Errors Continue with Little Change
Community/Ambulatory
Volume 17, Issue 5
This month's main topic: QuarterWatch™ (Quarter 3 2017): Emerging Risks with Inhaled Medications Using the Ellipta Device, the Controversy with Antidepressants, and Loperamide Abuse
Community/Ambulatory
Volume 17, Issue 4
This month's main topic: What's in a Generic Name? Clues about the Drug's Use and Possible Adverse Effects
Community/Ambulatory
Volume 17, Issue 3
This month's main topic: Improving Your Error Investigation Skills: Common Pitfalls when Conducting a Root Cause Analysis